LZTS2 and hepatocellular carcinoma: Therefore, our data indicate that LZTS2 is a new physiological substrate of the β-Trcp ubiquitin ligase and CK1δ protein kinase, which reveals a novel posttranscriptional modification of LZTS2 in HCC.